Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable Undifferentiated Pleomorphic Sarcoma or Dedifferentiated Liposarcoma Before Surgery

NCT03307616 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Dedifferentiated Liposarcoma
Recurrent Dedifferentiated Liposarcoma
Recurrent Undifferentiated Pleomorphic Sarcoma
Resectable Dedifferentiated Liposarcoma
Resectable Undifferentiated Pleomorphic Sarcoma
Undifferentiated Pleomorphic Sarcoma

Interventions

BIOLOGICAL: Ipilimumab
BIOLOGICAL: Nivolumab
RADIATION: Radiation Therapy

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]